The clinical utility of anti-ribosomal P autoantibodies in systemic lupus erythematosus

References

• O’Neill S, Cervera R. Systemic lupus erythematosus. Best Pract Res Clin Rheumatol 2010;24(6):841-55
   PubMedGoogle Scholar
• Tsokos GC. Mechanisms of disease: systemic lupus erytematosus. N Engl J Med 2011;365(22):2110-21
   PubMed Web of Science ®Google Scholar
• Walker SE. The epidemiology. In: Wallace DJ, Hahn B, editors. Dubois’ lupus erythematosus. 7th edition. Lippincott Williams & Wilkins; Philadelphia, USA: 2007. p. 286-98
   Google Scholar
• Petri M, Orbai AM, Alarcón GS, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012;64(8):2677-86
   PubMed Web of Science ®Google Scholar
• Rekvig OP, Putterman C, Casu C, et al. Autoantibodies in lupus: culprits or passive bystanders? Autoimmun Rev 2012;11(8):596-603
   PubMed Web of Science ®Google Scholar
• Cozzani E, Drosera M, Gasparini G, Parodi A. Serology of lupus erythematosus: correlation between immunopathological features and clinical aspects. Autoimmune Dis 2014. 2014:321359
   Google Scholar
• Tektonidou MG, Laskari K, Panagiotakos DB, Moutsopoulos HM. Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies. Arthritis Rheum 2009;61(1):29-36
   PubMedGoogle Scholar
• Elkon KB, Parnassa AP, Foster CL. Lupus autoantibodies target ribosomal P proteins. J Exp Med 1985;162(2):459-71
   PubMed Web of Science ®Google Scholar
• Elkon K, Skelly S, Parnassa A, et al. Identification and chemical synthesis of a ribosomal protein antigenic determinant in systemic lupus erythematosus. Proc Natl Acad Sci USA 1986;83(19):7419-23
   PubMed Web of Science ®Google Scholar
• Bonfa E, Golombek SJ, Kaufman LD, et al. Association between lupus psychosis and anti-ribosomal P protein antibodies. N Engl J Med 1987;317(5):265-71
   PubMed Web of Science ®Google Scholar
• Mahler M, Kessenbrock K, Szmyrka M, et al. International multicenter evaluation of autoantibodies to ribosomal P proteins. Clin Vaccine Immunol 2006;13(1):77-83
   PubMedGoogle Scholar
• Karassa FB, Afeltra A, Ambrozic A, et al. Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis. Arthritis Rheum 2006;54(1):312-24
   PubMedGoogle Scholar
• Olesińska M, Chwalińska-Sadowska H, Wiesik-Szewczyk E, et al. Clinical manifestation of systemic lupus erythematosus in patients with antiribosomal P protein antibodies. Pol Arch Med Wewn 2010;120(3):76-81
   PubMedGoogle Scholar
• Reichlin M, Wolfson-Reichlin M. Evidence for the participation of anti-ribosomal P antibodies in lupus nephritis. Arthritis Rheum 1999;420:12-2728-9
   Google Scholar
• Reichlin M, Wolfson-Reichlin M. Correlations of anti-dsDNA and anti-ribosomal P autoantibodies with lupus nephritis. Clin Immunol 2003;108(1):69-72
   PubMedGoogle Scholar
• Calich AL, Viana VS, Cancado E, et al. Anti-ribosomal P protein: a novel antibody in autoimmune hepatitis. Liver Int 2013;33(6):909-13
   PubMed Web of Science ®Google Scholar
• Abraham M, Derk CT. Anti-ribosomal-P antibodies in lupus nephritis, neuropsychiatric lupus, lupus hepatitis, and Chagas’ disease: promising yet limited in clinical utility. Rheumatol Int 2014. [Epub ahead of print]
   PubMedGoogle Scholar
• Mahler M, Ngo JT, Schulte-Pelkum J, et al. Limited reliability of the indirect immunofluorescence technique for the detection of anti-Rib-P antibodies. Arthritis Res Ther 2008;10(6):R131
   Google Scholar
• Muro Y, Sugiura K, Morita Y, Tomita Y. Evaluation of anti-ribosomal P protein immunoassay in Japanese patients with connective tissue diseases: comparison with an indirect immunofluorescence assay. Scand J Rheumatol 2009;38(6):460-3
   PubMed Web of Science ®Google Scholar
• Mahler M, Kessenbrock K, Raats J, et al. Characterization of the human autoimmune response to the major C-terminal epitope of the ribosomal P proteins. J Mol Med (Berl) 2003;81(3):194-204
   PubMedGoogle Scholar
• Hasler P, Brot N, Weissbach H, et al. The effect of phosphorylation and site-specific mutations in the immunodominant epitope of the human ribosomal P proteins. Clin Immunol Immunopathol 1994;72(2):273-9
   PubMedGoogle Scholar
• Fabien N, Moreira A, Lavergne JP, et al. Autoantibodies directed against the ribosomal P proteins are not only directed against a common epitope of the P0, P1 and P2 proteins. J Autoimmun 1999;13(1):103-10
   PubMedGoogle Scholar
• Agmon-Levin N, Gilburd B, Kivity S, et al. Anti-ribosomal-P antibodies in lupus patients and healthy controls: evaluation of three ELISA assays. Isr Med Assoc J 2009;11(7):403-6
   PubMedGoogle Scholar
• Hirohata S, Kasama T, Kawahito Y, Takabayashi K. Efficacy of anti-ribosomal P protein antibody testing for diagnosis of systemic lupus erythematosus. Mod Rheumatol 2014. [Epub ahead of print]
   Google Scholar
• Caponi L, Pegoraro S, Di Bartolo V, et al. Autoantibodies directed against ribosomal P proteins: use of a multiple antigen peptide as the coating agent in ELISA. J Immunol Methods 1995;179(2):193-202
   PubMedGoogle Scholar
• Lin JL, Dubljevic V, Fritzler MJ, Toh BH. Major immunoreactive domains of human ribosomal P proteins lie N-terminal to a homologous C-22 sequence: application to a novel ELISA for systemic lupus erythematosus. Clin Exp Immunol 2005;141(1):155-64
   PubMedGoogle Scholar
• Carmona-Fernandes D, Santos MJ, Canhão H, Fonseca JE. Anti-ribosomal P protein IgG autoantibodies in patients with systemic lupus erythematosus: diagnostic performance and clinical profile. BMC Med 2013;11:98
   PubMed Web of Science ®Google Scholar
• Mahler M, Agmon-Levin N, van Liempt M, et al. Multi-center evaluation of auto antibodies to the major ribosomal P C22 epitope. Rheumatol Int 2012;32(3):691-8
   PubMedGoogle Scholar
• Barkhudarova F, Dähnrich C, Rosemann A, et al. Diagnostic value and clinical laboratory associations of antibodies against recombinant ribosomal P0, P1 and P2 proteins and their native heterocomplex in a Caucasian cohort with systemic lupus erythematosus. Arthritis Res Ther 2011;13(1):R20
   Google Scholar
• Kleinnijenhuis J, van der Molen RG, Franssen PML, et al. Anti-ribosomal P antibodies as a single serological marker in SLE: lupus in disguise. Scand J Rheumatol 2013;42(2):165-6
   PubMed Web of Science ®Google Scholar
• Li J, Shen Y, He J, et al. Significance of antibodies against the native ribosomal P protein complex and recombinant P0, P1, and P2 proteins in the diagnosis of Chinese patients with systemic lupus erythematosus. J Clin Lab Anal 2013;27(2):87-95
   PubMedGoogle Scholar
• Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725
   PubMed Web of Science ®Google Scholar
• Haddouk S, Marzouk S, Jallouli M, et al. Clinical and diagnostic value of ribosomal P autoantibodies in systemic lupus erythematosus. Rheumatology (Oxford) 2009;48(8):953-7
   PubMed Web of Science ®Google Scholar
• Arnett FC, Reveille JD, Moutsopoulos HM, et al. Ribosomal P autoantibodies in systemic lupus erythematosus. Frequencies in different ethnic groups and clinical and immunogenetic associations. Arthritis Rheum. 1996;39(11):1833-9
   Google Scholar
• Gerli R, Caponi L, Tincani A, et al. Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: prospective evaluation in a large cohort of Italian patients. Rheumatology (Oxford) 2002;41(12):1357-66
   PubMedGoogle Scholar
• Massardo L, Burgos P, Martínez ME, et al. Antiribosomal P protein antibodies in Chilean SLE patients: no association with renal disease. Lupus 2002;11(6):379-83
   PubMedGoogle Scholar
• Karimifar M, Sharifi I, Shafiey K. Anti-ribosomal P antibodies related to depression in early clinical course of systemic lupus erythematosus. J Res Med Sci 2013;18(10):860-4
   PubMedGoogle Scholar
• Briani C, Lucchetta M, Ghirardello A, et al. Neurolupus is associated with anti-ribosomal P protein antibodies: an inception cohort study. J Autoimmun 2009;32(2):79-84
   PubMedGoogle Scholar
• Schneebaum AB, Singleton JD, West SG, et al. Association of psychiatric manifestations with antibodies to ribosomal P proteins in systemic lupus erythematosus. Am J Med 1991;90(1):54-62
   PubMedGoogle Scholar
• Teh LS, Hay EM, Amos N, et al. Anti-P antibodies are associated with psychiatric and focal cerebral disorders in patients with systemic lupus erythematosus. Br J Rheumatol 1993;32(4):287-90
   PubMedGoogle Scholar
• Hanly JG, Urowitz MB, Siannis F, et al. Systemic Lupus International Collaborating Clinics. Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study. Arthritis Rheum 2008;58(3):843-53
   PubMedGoogle Scholar
• Chindalore V, Neas B, Reichlin M. The association between anti-ribosomal P antibodies and active nephritis in systemic lupus erythematosus. Clin Immunol Immunopathol 1998;87(3):292-6
   PubMedGoogle Scholar
• Nagai T, Arinuma Y, Yanagida T, et al. Anti-ribosomal P protein antibody in human systemic lupus erythematosus up-regulates the expression of proinflammatory cytokines by human peripheral blood monocytes. Arthritis Rheum 2005;52(3):847-55
   PubMedGoogle Scholar
• Nagai T, Yanagida T, Hirohata S. Anti-ribosomal P protein antibody induces Th1 responses by enhancing the production of IL-12 in activated monocytes. Mod Rheumatol 2011;21(1):57-62
   PubMed Web of Science ®Google Scholar
• Sun KH, Tang SJ, Lin ML, et al. Monoclonal antibodies against human ribosomal P proteins penetrate into living cells and cause apoptosis of Jurkat T cells in culture. Rheumatology (Oxford) 2001;40:750-6
   PubMed Web of Science ®Google Scholar
• Pisoni CN, Muñoz SA, Carrizo C, et al. Multicentric prevalence study of anti P ribosomal autoantibodies in juvenile onset systemic lupus erythematosus compared with adult onset systemic lupus erythematosus. Reumatol Clin 2014; pii: S1699-258X(14)00083-7. [Epub ahead of print]
   PubMedGoogle Scholar
• Reichlin M, Broyles TF, Hubscher O, et al. Prevalence of autoantibodies to ribosomal P proteins in juvenile-onset systemic lupus erythematosus compared with the adult disease. Arthritis Rheum 1999;42(1):69-75
   PubMedGoogle Scholar
• Press J, Palayew K, Laxer RM, et al. Antiribosomal P antibodies in pediatric patients with systemic lupus erythematosus and psychosis. Arthritis Rheum 1996;39(4):671-6
   PubMedGoogle Scholar
• Aldar H, Lapa AT, Bellini B, et al. Prevalence and clinical significance of anti-ribosomal P antibody in childhood-onset systemic lupus erythematosus. Lupus 2012;21(11):1225-31
   PubMed Web of Science ®Google Scholar
• Mostafa GA, Ibrahim DH, Shehab AA, Mohammed AK. The role of measurement of serum autoantibodies in prediction of pediatric neuropsychiatric systemic lupus erythematosus. J Neuroimmunol 2010;227(1-2):195-201
   PubMedGoogle Scholar
• Smith PP, Gordon C. Systemic lupus erythematosus: clinical presentations. Autoimmun Rev 2010;10(1):43-5
   PubMed Web of Science ®Google Scholar
• The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999;42(4):599-608
   PubMed Web of Science ®Google Scholar
• van Dam A, Nossent H, de Jong J, et al. Diagnostic value of antibodies against ribosomal phosphoproteins. A cross sectional and longitudinal study. J Rheumatol 1991;18(7):1026-34
   PubMedGoogle Scholar
• Teh LS, Bedwell AE, Isenberg DA, et al. Antibodies to protein P in systemic lupus erythematosus. Ann Rheum Dis 1992;51(4):489-94
   PubMedGoogle Scholar
• Almeida D, Antolín J, Amérigo MJ, et al. Anti-ribosomal antibodies as activity markers in systemic lupus erythematosus. An Med Interna 2002;19(2):73-5
   PubMedGoogle Scholar
• Conti F, Alessandri C, Bompane D, et al. Autoantibody profile in systemic lupus erythematosus with psychiatric manifestations: a role for anti-endothelial-cell antibodies. Arthritis Res Ther 2004;6(4):R366-72
   PubMed Web of Science ®Google Scholar
• Chandran V, Upadhyaya SK, Haroon N, et al. Lack of clinical association with antibodies to ribosomal P proteins in Indian patients with systemic lupus erythematosus. J Rheumatol 2006;33(10):1987-9
   PubMedGoogle Scholar
• De Carvalho JF, TrindadeViana VS, Bonfá E. Deciphering the association of anti P ribosomal antibodies and neuropsychiatric affection in systemic lupus erythematosus. Reumatol Clin 2010;6(2):73-5
   PubMedGoogle Scholar
• Isshi K, Hirohata S. Association of anti-ribosomal P protein antibodies with neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 1996;39:1483-90; Erratum in: Arthritis Rheum 1997; 40: 977
   PubMed Web of Science ®Google Scholar
• Ghirardello A, Briani C, Lucchetta M, Doria A. Anti-ribosomal P protein antibodies and neuropsychiatric systemic lupus erythematosus: cross-sectional vs. prospective studies. Lupus 2010;19(6):771-3
   PubMedGoogle Scholar
• Hanly JG, Urowitz MB, Su L, et al. Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus. Ann Rheum Dis 2011;70(10):1726-32
   PubMed Web of Science ®Google Scholar
• Yoshio T, Hirata D, Onda K, et al. Antiribosomal P protein antibodies in cerebrospinal fluid are associated with neuropsychiatric systemic lupus erythematosus. J Rheumatol 2005;32(1):34-9
   PubMed Web of Science ®Google Scholar
• Hirohata S, Arinuma Y, Takayama M, Yoshio T. Association of cerebrospinal fluid anti-ribosomal p protein antibodies with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus. Arthritis Res Ther 2007;9:R44
   PubMed Web of Science ®Google Scholar
• Koren E, Reichlin MW, Koscec M, et al. Autoantibodies to the ribosomal P proteins react with a plasma membrane-related target on human cells. J Clin Invest 1992;89(4):1236-41
   PubMedGoogle Scholar
• Matus S, Burgos PV, Bravo-Zehnder M, et al. Antiribosomal-P autoantibodies from psychiatric lupus target a novel neuronal surface protein causing calcium influx and apoptosis. J Exp Med 2007;204(13):3221-334
   PubMed Web of Science ®Google Scholar
• Katzav A, Solodeev I, Brodsky O, et al. Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system. Arthritis Rheum 2007;56(3):938-48
   PubMedGoogle Scholar
• Katzav A, Ben-Ziv T, Chapman J, et al. Anti-P ribosomal antibodies induce defect in smell capability in a model of CNS-SLE (depression). J Autoimmun 2008;31(4):393-8
   PubMed Web of Science ®Google Scholar
• Weening JJ, D’Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 2004;15:241-50
   PubMed Web of Science ®Google Scholar
• Quintana G, Coral-Alvarado P, Aroca G, et al. Single anti-P ribosomal antibodies are not associated with lupus nephritis in patients suffering from active systemic lupus erythematosus. Autoimmun Rev 2010;9(11):750-5
   PubMedGoogle Scholar
• do Nascimento AP, Viana V dos S, Testagrossa L de A, et al. Antibodies to ribosomal P proteins: a potential serologic marker for lupus membranous glomerulonephritis. Arthritis Rheum 2006;54(5):1568-72
   PubMedGoogle Scholar
• Bertolaccini ML, Murru V, Alba P, Khamashta MA. Lack of association of antibodies to ribosomal P proteins with lupus membranous glomerulonephritis: comment on the article by Do Nascimento et al. Arthritis Rheum 2006;54(12):4025-6; author reply 4026-4027
   PubMedGoogle Scholar
• de Macedo PA, Borba EF, Viana V dos S, et al. Antibodies to ribosomal P proteins in lupus nephritis: a surrogate marker for a better renal survival? Autoimmun Rev 2011;10(3):126-30
   PubMedGoogle Scholar
• Hirohata S. Anti-ribosomal P antibodies and lupus nephritis. Clin Exp Nephrol 2011;15(4):471-7
   PubMed Web of Science ®Google Scholar
• Sun KH, Liu WT, Tang SJ, et al. The expression of acidic ribosomal phosphoproteins on the surface membrane of different tissues in autoimmune and normal mice which are the target molecules for anti-double-stranded DNA antibodies. Immunology 1996;87(3):362-71
   PubMed Web of Science ®Google Scholar
• Ben-Ami Shor D, Blank M, Reuter S, et al. Anti-ribosomal-P antibodies accelerate lupus glomerulonephritis and induce lupus nephritis in naïve mice. J Autoimmun 2014; pii: S0896-8411(14)00064-X. [Epub ahead of print]
   Google Scholar
• Ohira H, Takiguchi J, Rai T, et al. High frequency of anti-ribosomal P antibody in patients with systemic lupus erythematosus-associated hepatitis. Hepatol Res 2004;28(3):137-9
   PubMedGoogle Scholar
• Koscec M, Koren E, Wolfson-Reichlin M, et al. Autoantibodies to ribosomal P proteins penetrate into live hepatocytes and cause cellular dysfunction in culture. J Immunol 1997;159(4):2033-41
   PubMedGoogle Scholar
• Ghirardello A, Doria A, Zampieri S, et al. Anti-ribosomal P protein antibodies detected by immunoblotting in patients with connective tissue diseases: their specificity for SLE and association with IgG anticardiolipin antibodies. Ann Rheum Dis 2000;59(12):975-81
   PubMedGoogle Scholar
• Fujimoto M, Sato S, Takehara K, et al. Detection of antiribosomal P protein antibodies in patients with systemic sclerosis. Rheumatology 1995;34(10):908-11
   Google Scholar
• Sánchez-Sancho F, Campillo NE, Páez JA. Chagas disease: progress and new perspectives. Curr Med Chem 2010;17(5):423-52
   PubMedGoogle Scholar
• Bonfa E, Viana VS, Barreto AC, et al. Autoantibodies in Chagas’ disease. An antibody cross-reactive with human and Trypanosoma cruzi ribosomal proteins. J Immunol 1993;150(9):3917-23
   PubMedGoogle Scholar
• Kaplan D, Ferrari I, Bergami PL, et al. Antibodies to ribosomal P proteins of Trypanosoma cruzi in Chagas disease possess functional autoreactivity with heart tissue and differ from anti-P autoantibodies in lupus. Proc Natl Acad Sci USA 1997;94(19):10301-6
   PubMedGoogle Scholar
• Grippo V, Niborski LL, Gomez KA, Levin MJ. Human recombinant antibodies against Trypanosoma cruzi ribosomal P2β protein. Parasitology 2011;138(6):736-47
   PubMedGoogle Scholar
• Levin MJ. Molecular mimicry and Chagas heart disease: high anti-R-13 autoantibody levels are markers of severe heart complaint. Res Immunol 1991;142(2):157-9
   PubMedGoogle Scholar
• Aznar C, Lopez Bergami P, Brandariz S, et al. Prevalence of anti-R-13 antibodies in human Trypanosomacruzi infection. FEMS Immunol Med Microbiol 1995;12(3-4):231-8
   PubMedGoogle Scholar